Cart
Hi , Your cart is empty
Prescribe With Confidence!
Prescribe Interactively
Control the formulation of your patient's compounded medications interactively. Choose the base, adjust active ingredients, see estimated cost, certificate of Analysis, Stability studies, get allergen or GMO declarations, Safety Data Sheets (SDS), -- Just to name a few as you create the prescription.
Benefits
In pharmaceutical compounding, there are differences among the
These factors drive the active pharmaceutical ingredients (APIs) to how you, the prescriber, expect it to act therapeutically.
Now you can build the perfect product for your patient Interactively. This is real customization.
1. Choose The Right Base ---- Use comparison charts to see what is appropriate for your patient.
2. Choose Active Ingredients --- Review Safety Data Sheets (SDS) and other information interactively.
3. Add Cosmetically Active Ingredients, Flavor, Preservative Free, others using a slider.
4. See Rx Prices As You Go ... See how much the Rx will cost as you create the prescription.
5. Choose Appropriate Delivery Device ... Airless dispensers, Pumps, Dosing Syringes, Foamers ...
6. Instant Access To Safety Data Sheets (SDS), Allergen Information, .....
7. Access Reference and Comparison Charts as you create the prescription.
8. Customize Your Patient's Prescriptions just the way you want it.
9. Build With Confidence! --Your patients deserve it.
10. Generate a Prescription ... For your specific patient.
Liposome and nanoemulsion technology, Plant stem cell culture production, Snow algae biotechnology, Plant extracts, Peptide design, CM-Glucan production.
Get inspired by the latest products from partners such as Mibelle Biochemistry, Switzerland. This Swiss company use innovative and cutting-edge technology in developing top-quality natural active ingredients for skincare, hair care and nutraceutical supplements. Explore AnaGain for simulating hair growth and fighting hair loss. Incorporate CM-Glucan Forte in your formulation to rebalance the skin's immunce system.
The FDA defines pharmaceutical compounding as a practice in which a licensed pharmacist, a licensed physician, or, in the case of an outsourcing facility, a person under the supervision of a licensed pharmacist, combines, mixes, or alters ingredients of a drug to create a medication tailored to the needs of an individual patient.
Questions? Email FDA’s compounding team at compounding@fda.hhs.gov.
According to the FDA, compounded drugs can serve an important medical need for patients who cannot be treated with an FDA-approved medication, such as a patient who has an allergy and needs a drug to be made without a certain dye, or an elderly patient or a child who cannot swallow a tablet or capsule and needs a medicine in a liquid dosage form.
Practitioners in hospitals, clinics, and other health care facilities sometimes provide compounded drugs to patients when an FDA-approved drug is not medically appropriate to treat them.
Pharmaceutical compounding give providers the opportunity to:
Compounded drugs are not FDA-approved. This means that FDA does not verify the safety or effectiveness of compounded drugs. Compounded drugs also lack an FDA finding of manufacturing quality before such drugs are marketed.
This is a major reason for prescribers to partner with pharmaceutical compounders that can provide them with as much information to make a patient care decision.
The Pharmacists at Red Apple realize that you need this information while creating the prescription. They came up with an interactive application to achieve this goal.
Various entities may inspect facilities that compound drugs, including state boards of pharmacy and FDA.
Generally, state boards of pharmacy have primary responsibility for the day-to-day oversight of state-licensed pharmacies that are not registered with FDA as outsourcing facilities. FDA does conduct surveillance and for-cause inspections of state-licensed pharmacies that are not registered as outsourcing facilities.
No. Biological products are not eligible for the exemptions for compounded drugs under sections 503A and 503B of the Federal Food, Drug, and Cosmetic (FD&C) Act. Federal law does not provide a legal pathway for marketing biologics that have been prepared outside the scope of an approved biologics license application.
Unfortunately No. But guess what? Most compounded medications are far cheaper than commercially available dosage forms.
Workflow.
